Aldeyra Therapeutics Company
Aldeyra Therapeutics develops next-generation medicines to improve the lives of patients with immune-mediated diseases.
Estimated Revenue:
Less than $1M
Funding Status:
IPO
Employee Number:
11-50
Industry:
PharmTech
Headquarters:
Burlington, Massachusetts, United States
Founded Date:
2004
Technology:
Cancer